How AI can help to tackle COVID-19
Loubna Bouarfa
CEO, Okra Technologies, Cambridge, UK
Michel Bouvier
CEO, Institute for Research in Immunology and Cancer, Université de Montréal, Canada
Giovanni Briganti
Senior fellow, I3h Institute, Université libre de Bruxelles, Belgium
Michel Goldman
Founder of the I3h Institute
Philippe Moingeon
Head of Immuno-inflammation, Servier Pharmaceuticals, Neuilly-sur-Seine, France